Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
PISCATAWAY, N.J. — Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
Diclofenac Potassium for Oral Solution is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura, in adults 18 years of age or older.
Diclofenac Potassium for Oral Solution is available in 50 mg strength and supplied as a box of 9 individual packets.
Replenza is a cutting-edge support system created specifically for individuals using GLP-1 medications, which have gained widespread popularity for weight loss and management.
For the second year in a row, Walgreens has announced it will close most of its retail stores for the Thanksgiving holiday.
“Automating tasks allows pharmacies to handle increased demand without compromising quality," says Kevin Cloutier, vice president and general manager of McKesson Pharmacy Automation.
Designed to meet the needs of the 85% of consumers seeking whiter teeth, this new product promises to deliver noticeable whitening results safely in just one day—setting a new standard in the industry.
This renewed sense of confidence is reflected in shoppers' strategies for the holidays.
Replenza is a cutting-edge support system created specifically for individuals using GLP-1 medications, which have gained widespread popularity for weight loss and management.
The partnership marks Henkel's first-ever portfolio deal and will leverage a range of its more than 30 popular brands in North America, to promote the U.S. Men's and Women's National Teams.
